| Product Information |
|
| Registration Number |
DR-XY44446
|
| Generic Name |
Cefepime (as hydrochloride) + Tazobactam (as sodium)
|
| Brand Name |
Saptaz
|
| Dosage Strength |
1 g/125 mg
|
| Dosage Form |
Powder for Injection (IM/IV)
|
| Classification |
Prescription Drug (RX)
|
| Pharmacologic Category |
Antibacterial (Beta-lactamase inhibitor)
|
| Packaging |
20mL Type I clear colorless glass vial + 10mL Type I clear
colorless ampoule (diluent) in a plastic tray per box
|
| Manufacturer |
Makcur Laboratories Ltd.
|
| Country of Origin |
India
|
| Trader |
|
| Importer |
SRS Life Sciences Inc.
|
| Distributor |
Bell Kenz Pharma Inc.
|
| Application Type |
Renewal
|
| Issuance Date |
25 March 2022
|
| Expiry Date |
17 April 2025
|